The influence of guideline revisions on the process and outcome of hypertension management in general practice: A descriptive study

European Journal of General Practice

Volumn 14, Issue SUPPL. 1, 2008, Pages 47-52

  van der Wel, Mark ^a   Bakx, Carel ^a   de Grauw, Wim ^a   van Gerwen, Willem ^a   Mulder, Jan ^a   van Weel, Chris ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

General practice; Guidelines; Hypertension; Management; Quality of care

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; DATA BASE; DRUG CHOICE; DRUG USE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NETHERLANDS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PULSE PRESSURE;

AGE FACTORS; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; DIASTOLE; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; REGISTRIES; SYSTOLE;

EID: 55049115098     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.1080/13814780802436200     Document Type: Article

References (16)

1. Van Binsbergen, JJ, Grundmeyer, HGLM, Van den Hoogen, JPH, Van Kruysdijk, M., Prins, A. van Ree, JW et al. (1991) NHG-standaard hypertensie. Huisarts en Wetenschap, 34, pp. 389-395.
2. Walma, EP, Grundmeyer, HGLM, Thomas, S., Prins, A., Van den Hoogen, JPH and Van der Laan, JR. (1997) NHG-standaard hypertensie (eerste herziening). Huisarts en Wetenschap, 40:12, pp. 598-617.
3. Walma, EP, Thomas, S., Prins, A., Grundmeyer, HGLM, Van der Laan, JR and Wiersma, T. (2003) NHG-standaard hypertensie (derde herziening). Huisarts en Wetenschap, 46:8, pp. 435-449.
4. Mancia, G., De, BG, Dominiczak, A., Cifkova, R., Fagard, R. Germano, G. et al. (2007) Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J, 28:12, pp. 1462-1536.
5. Summary of 1993 World Health Organisation (1993) International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison Committee. BMJ, 307:6918, pp. 1541-1546.
6. Chobanian, AV, Bakris, GL, Black, HR, Cushman, WC, Green, LA Izzo Jr, JL et al. (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 289:19, pp. 2560-2572.
7. Wang, TJ and Vasan, RS. (2005) Epidemiology of uncontrolled hypertension in the United States. Circulation, 112:11, pp. 1651-1662.
8. Manning, G., Brooks, A., Slinn, B., Millar-Craig, MW and Donnelly, R. (2006) Assessing blood pressure control in patients treated for hypertension: Comparing different measurements and targets. Br J Gen Pract, 56:526, pp. 375-377.
9. (2006)
10. Hajjar, I. and Kotchen, TA. (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA, 290:2, pp. 199-206.
11. Kearney, PM, Whelton, M., Reynolds, K., Muntner, P., Whelton, PK and He, J. (2005) Global burden of hypertension: Analysis of worldwide data. Lancet, 365:9455, pp. 217-223.
12. Walley, T., Duggan, AK, Haycox, AR and Niziol, CJ. (2003) Treatment for newly diagnosed hypertension: Patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med, 96:11, pp. 525-531.
13. Pittrow, D., Kirch, W., Bramlage, P., Lehnert, H., Hofler, M. Unger, T. et al. (2004) Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol, 60:2, pp. 135-142.
14. Staessen, JA, Fagard, R., Thijs, L., Celis, H., Arabidze, GG Birkenhager, WH et al. (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet, 350:9080, pp. 757-764.
15. (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, 288:23, pp. 2981-2997.
16. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension (1991) Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA, 265:24, pp. 3255-3264.